In sporadic PD patients, dysregulated IFNβ signaling was identified as the top candidate pathway associated with disease and its progression to dementia, and subsequent meta-analysis of GWAS recognized sequence variants in IFNβ-IFNAR signaling pathway related genes [28]. This evidence concerns the gene IFNB1 and Parkinson disease.